Inspired by the tumor-suppressive efficacy of C/M@Alb NCs against orthotopic breast cancer and lung metastasis, we further exploited the therapeutic efficacy of C/M@Alb NCs against hostile PDX lung tumors. This evidence concerns the gene ALB and neoplasm.